ARTERIOSCLEROSIS
Clinical trials for ARTERIOSCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new ARTERIOSCLEROSIS trials appear
Sign up with your email to follow new studies for ARTERIOSCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New stent study aims to clear heart blockages safely
Disease control OngoingThis study tests a special stent (a small mesh tube) coated with a drug that helps keep heart arteries open. It involves 591 people in China with narrowed arteries who need a procedure to restore blood flow. The goal is to see if the stent is safe and effective at treating blocka…
Matched conditions: ARTERIOSCLEROSIS
Phase: NA • Sponsor: Medtronic Vascular • Aim: Disease control
Last updated May 26, 2026 04:10 UTC
-
New pill could slash heart attacks and strokes in High-Risk patients
Disease control OngoingThis study tests an experimental daily pill, MK-0616, to see if it can prevent major heart problems like heart attacks, strokes, and blocked arteries in people with high risk due to hardening of the arteries and high cholesterol. About 14,550 adults will take either the pill or a…
Matched conditions: ARTERIOSCLEROSIS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 03:53 UTC
-
New stent vs. old stent: which keeps arteries open better?
Disease control OngoingThis study tests a newer heart stent (Resolute Onyx) against an older one (Resolute Integrity) in 550 people in China with narrowed arteries. Both stents are drug-coated tubes that prop open arteries and release medicine to prevent re-blockage. The main goal is to see which stent…
Matched conditions: ARTERIOSCLEROSIS
Phase: NA • Sponsor: Medtronic Vascular • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Heart test revolution: smarter screening spares thousands from unneeded scans
Diagnosis ENROLLING_BY_INVITATIONThis study tests whether using personalized risk models can safely reduce the number of diagnostic tests needed for people with new, stable chest pain. Researchers will compare this approach to standard care in 2000 adults aged 30-75. They will also test a new laser method to mea…
Matched conditions: ARTERIOSCLEROSIS
Phase: PHASE3 • Sponsor: Gødstrup Hospital • Aim: Diagnosis
Last updated May 26, 2026 04:07 UTC